Citius Pharmaceuticals Inc (NAS:CTXR)
$ 0.4783 0.033 (7.35%) Market Cap: 86.44 Mil Enterprise Value: 63.59 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 32/100

Citius Pharmaceuticals Inc CEORoadshow Interview with Leonard Mazur Transcript

Jul 10, 2020 / NTS GMT
Release Date Price: $1.34 (+3.88%)
Mike Elliot
CEORoadshow - Moderator

Hi, I am Mike Elliot and you're watching CEORoadshow. Today we're joined by Mr. Leonard Mazur. He is the Chairman of Citius Pharmaceutics, a specialty pharmaceutical company focused on developing and commercializing critical care products. Their stock trades in the Nasdaq under CTXR.

Good morning, Leonard, and welcome to the show.

Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO & Chairman

Good morning, Mike, thank you for having me on, really appreciate it.

Questions & Answers

Mike Elliot
CEORoadshow - Moderator

Well, it's great to catch with you again.

And I guess to start off, just for investors new to the story, tell us how the company was founded.

Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO & Chairman

All right. So, the history of the company is that the roots of it are with a private company that my partner, Myron Holubiak, who is the CEO, and I formed called

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot